Lentigen Corporation is always looking to develop collaborative relationships, and build ongoing partnerships which broaden the future for Lentiviral vectors. Lentigen welcomes establishing relationships with academic institutions and biopharmaceutical companies that require highly efficient gene delivery solutions for their specific applications.

If this is of interest to you, please contact our Vice President of Business Development, Greg Feulner, at 443.543.5318 or greg.feulner@lentigen.com.